Free Republic

Some 93% of 90 coronavirus serious patients treated in several Greek hospitals with a new drug developed by a team at Tel Aviv’s Sourasky Medical Center as part of the Phase II trial of the treatment were discharged in five days or fewer. The Phase II trial confirmed the results of Phase I, which was conducted in Israel last winter and saw 29 out of 30 patients in moderate to serious condition recover within days. “The main goal of this study was to verify that the drug is safe,” Prof. Nadir Arber said. “To this day we have not registered...

Israel’s “precision medicine” for COVID-19, which tackles the immune overreaction that causes deterioration from the disease, will start a second round of clinical trials in Greece next week. The testing comes with interest in coronavirus drugs sky-high, amid spiraling cases in several countries where widespread vaccine protection isn’t expected anytime soon, including India, where there are more than 300,000 new cases per day, and Nepal, where hospitals are struggling. The inhaled drug EXO-CD24 was given to 30 patients in moderate condition or worse, and all of them recovered, 29 of them within three to five days. In February Tel Aviv’s...

Researchers from Tel Aviv’s Ichilov Medical Center developed a coronavirus therapy that was found to cure COVID-19 in 3-5 days in most volunteers who received the drug. EXO-CD24 is a medication delivered directly to the lungs, where it’ll help prevent the immune system dealing with COVID-19 from overreacting and causing complications. The drug is administered once a day for five minutes via inhalation. In Phase 1 trials, 29 out of 30 people suffering from moderate to severe COVID-19 recovered within 3-5 days, and all of them survived.

Experimental Covid drug cures 30 out of 30 moderate to severe cases in Phase I clinical trial at Israeli hospital. Second new drug also shows promise.Even with Israel’s world-leading rollout of Covid-19 vaccinations, drugs to treat Covid patients are in desperate need across the world. Two such drugs developed in Israel show great promise in clinical trials: EXO-CD24 and Allocetra. EXO-CD24, an experimental inhaled medication developed at Tel Aviv Sourasky Medical Center, cured all 30 moderate-to-severe cases in a Phase I clinical trial. Developed over the past six months at the hospital, EXOCD24 stops the “cytokine storm” – where the...

A new coronavirus treatment developed at Tel Aviv’s Ichilov Medical Center appears to have cured 29 of 30 moderately-ill and seriously-ill COVID-19 patients, the hospital said. The patients were released within 3 to 5 days of being treated.. This was only the first stage of trials and many months and thousands of patients will have to be treated before anything definitive can be said about the treatment. But the drug apparently works on the immune system to prevent a cytokine storm, which often leads to critical illness and death. Nadir Arber, the professor who invented the potential treatment, hailed the...